IMI has had ‘big data’ projects since its creation.  What’s more, the projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease, haematological malignancies (blood cancers), Alzheimer’s disease, and prostate cancer. IMI also boasts a number of projects working on health-related mobile and digital technologies.

This event was part of  a series of  live sessions that IMI is organising on IMI Impacts, where key actors explored the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we also shared patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.

Furthermore, we engaged IMI stakeholders in a broader discussion on IMI’s impact. With this initiative, we demonstrated the successful IMI model of radical collaboration.